Pub. Date : 2011 Sep
PMID : 20711688
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | DISCUSSION: In patients with known BRCA 1 or 2 mutation-associated pancreatic adenocarcinoma, the addition of a DNA cross-linking agent such as cisplatin, oxaliplatin, or mitomycin to a standard gemcitabine chemotherapy backbone should be considered. | Mitomycin | BRCA1 DNA repair associated | Homo sapiens |